ESC 365 - Assess of angiotensin receptor blockers therapy associated to mineralocorticoid receptor antagonists or to calcium channel blockers plus hydrochlorothiazide according central haemodynamic parameters

ESC Premium Access

Assess of angiotensin receptor blockers therapy associated to mineralocorticoid receptor antagonists or to calcium channel blockers plus hydrochlorothiazide according central haemodynamic parameters

Session: Poster Session 5 - Hypertension treatment: drugs and devices

Topic: Pharmacotherapy

Speaker: Doctor C. Paterno Marchioli (Castiglion Fiorentino (AR), IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Carlos Alberto Paterno Marchioli

Cardiovascular Research Laboratory., Castiglion Fiorentino (AR) (Italy)

0 follower

14 more presentations in this session

Central-acting aminopeptidase a inhibitors for new treatment of hypertension: from discovery to clinical trial.

Speaker: Doctor R. Hmazzou (Paris, FR)

Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: A 6-week randomised, multicentre, double-blind study followed by open-label phase

Speaker: Doctor K. Bapatla (Hyderabad, IN)

Thrombin generation and platelet function in patients on RAAS inhibitors

Speaker: Doctor C. Helten (Duesseldorf, DE)

Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study

Speaker: Doctor E. Chowdhury (Perth, AU)

Hemodynamic management of resistant hypertension

Speaker: Doctor F. Chacon-Lozsan (Budapest, HU)

Access the full session

Poster Session 5 - Hypertension treatment: drugs and devices

Speakers: Doctor C. Paterno Marchioli, Doctor R. Hmazzou, Doctor K. Bapatla, Doctor C. Helten, Doctor E. Chowdhury...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources